GL1X · GenesisL1 explorer

Research workbench

Crystal structures in an anti-HIV antibody lineage from immunization of rhesus macaques

Analyse Crystal structures in an anti-HIV antibody lineage from immunization of rhesus… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5DD5
Type
protein
Length
438 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-HIV antibody DH570.9 Fab heavy chain
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HAnti-HIV antibody DH570.9 Fab heavy chainprotein2258% helix, 51% strand—
LAnti-HIV antibody DH570.9 Fab heavy chainprotein2137% helix, 52% strand—

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1560.570.9019empty
22340.530.7637empty
32420.490.7437empty

Interfaces

1 interface between chains.

  • H–L · 1863 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5DD5 · Crystal structures in an anti-HIV antibody lineage from immunization of Rhesus macaques · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.